In humans, there is a loss of parvalbumin-expressing interneurons in the striatum and cortex of advanced symptomatic HD patients (Thu et al., 2010; Reiner et al., 2013), which would imply that these interneurons undergo cellular changes resulting in a diminution of inhibitory inputs onto CPNs. Here, PVALB is linked to Huntington disease.